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Available online 19 October 2016Schistosomiasis is a chronic disease caused by the parasite of the Schistosoma genus and is characterized by egg-
induced hepatic granulomas and ﬁbrosis. Macrophages play a central role in schistosomiasis with several studies
highlighting their differentiation into M2 cells involved in the survival of infectedmice through limitation of im-
munopathology. However, little is known regarding the mechanisms of regulating macrophage differentiation.
Here, we showed that the early stage of infection by Schistosoma japonicum induced expression of type 1 T-help-
er-cell (Th1) cytokine, interferon-γ (IFN-γ), leading to increase in M1 cells. However, the presence of liver-
trapped eggs induced the expression of Th2 cytokines including interleukin-4 (IL-4), IL-10, and IL-13 that upreg-
ulated the transcription ofmiR-146b by activating signal transducer and activator of transcription 3/6 (STAT3/6)
that bind to the promoter of the pre-miR-146b gene.We found that themiR-146a/bwas signiﬁcantly upregulated
inmacrophages during the progression of hepatic schistosomiasis. The elevatedmiR-146a/b inhibited the IFN-γ-
induced differentiation of macrophages to M1 cells through targeting STAT1. Our data indicate the protective
roles of miR-146a/b in hepatic schistosomiasis through regulating the differentiation of macrophages into M2
cells.






Schistosomiasis is a neglected tropical and sub-tropical parasitic dis-
ease, caused by blood-dwelling ﬂuke worms of the genus Schistosoma,
affecting N230 million people worldwide (Colley et al., 2014). The pri-
mary pathology of schistosomiasis is egg-induced granuloma and ﬁbro-
sis, which is a result of the host immune response to the eggs. In the
early phase of infection, a type 1 T-helper-cell (Th1) response is induced
by the migration of the schistosomula and adult worms and is charac-
terized by the elevation of interferon-γ (IFN-γ) levels. Host immune re-
sponse is later polarized into a Th2 response, initiated by the release of
eggs occurring 4–6 weeks post-infection, featuring an increase in the
levels of interleukin-4 (IL-4), IL-13, etc. (Pearce and MacDonald, 2002;
Burke et al., 2009). These Th1 and Th2-related cytokines play a decisive
role in the pathogenesis of schistosomiasis.
Macrophages play a vital role in the liver pathology caused by
Schistosoma (Barron and Wynn, 2011). They regulate the initiation,ctiousDiseases, SecondMilitary
ghai 200433, China.
), wqpan0912@aliyun.com
. This is an open access article undermaintenance, and resolution of this chronic inﬂammatory disease and
their function depends on their activation status. Macrophages can be
classically activated (M1 macrophages) or alternatively activated (M2
macrophages) depending on the local immune environment (Kreider
et al., 2007; Noël et al., 2004; Sica and Mantovani, 2012). M1 macro-
phages are induced by Th1 cytokines or microbial molecules such as
lipopolysaccharide (LPS), while M2 macrophages are stimulated by
Th2 cytokines. M1 macrophages primarily produce pro-inﬂammatory
cytokines such as tumour necrosis factor α (TNF-α), IL-1β, IL-12, and
IL-23. M2 macrophages are involved in Th2-biased response producing
cytokines such as transforming growth factor β (TGF-β) and IL-10 lead-
ing to parasite clearance and host protection.
MicroRNAs (miRNAs) are a class of endogenous, small noncoding
RNA molecules, which control the translation and transcription of
many genes (Bartel, 2004, 2009; Ma et al., 2011). Numerous studies
have demonstrated that miRNAs play a crucial role in many human dis-
eases including schistosomiasis (He et al., 2013, 2015; Cai et al., 2013,
2016; Han et al., 2013). Our previous study using miRNA microarrays
demonstrated that a series of miRNAs were deregulated in the progres-
sion of hepatic schistosomiasis in a mouse model. Importantly, miR-21,
one of the upregulated miRNAs, was involved in the regulation of acti-
vation of hepatic stellate cells (HSCs) and downregulation of miR-21
prevented lethal infection by repressing both TGF-β1 and IL-13 path-
ways (He et al., 2015).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
340 X. He et al. / EBioMedicine 13 (2016) 339–347In this study, we used a murine model of Schistosoma japonicum (S.
japonicum) to investigate the roles of miR-146a/b, two upregulated
miRNAs identiﬁed in our previous study (He et al., 2015), in theprogres-
sion of hepatic schistosomiasis. We found miR-146 was primarily
expressed in hepatic macrophages, and inhibited the differentiation of
macrophages to M1 cells by targeting signal transducer and activator
of transcription 1 (STAT1), a crucial molecule in IFN-γ signalling. In ad-
dition, a series of Th2 cytokines, including IL-4, IL-10, and IL-13, induced
the expression of miR-146b by activating STAT3/6 in macrophages, and
thus prevented the differentiation of macrophages into M1 cells.
2. Methods
2.1. Ethics statement
All animal experiments were undertaken in strict accordance with
the Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health, andwere approved by theAnimal Ethics Committee
of SecondMilitaryMedical University (laboratory animal usage number
FYXK (Shanghai) 2014–0003). To minimize pain and discomfort, all an-
imal surgeries were performed under sodium pentobarbital anaesthe-
sia. All mice used in this study were purchased from the Experimental
Animal Center of the Second Military Medical University, and were
housed in speciﬁc pathogen-free conditions and fed autoclaved food
and water as needed.
2.2. Schistosome infection and sample preparation
To establish the animal model of schistosomiasis, six-week-old
BABL/c male mice were exposed percutaneously to 16 S. japonicum cer-
cariae shed from lab-infected snails (Oncomelania hupensis), obtained
from the Institute of Parasitic Disease, Shanghai.
For collection of liver samples, 24 mice were infected and six mice
each were sacriﬁced on days 21, 32, 42 and 52 post-infection. In addi-
tion, six uninfected mice were used as control samples and were
sacriﬁced on day 0. To collect blood from the portal vein, the abdominal
cavity of mouse was opened after anesthetization, then portal vein was
penetrated with sterile single-use syringe for insulin to drain blood.
After collecting blood, portal vein was dissected at the root, then the
thoracic cavity of mouse was opened and the circulatory system was
perfused via the aorta with 20 mL of sterile PBS, and worms were col-
lected and counted in a sterile petri dish containing medium as de-
scribed previously (Shainheit et al., 2008). Subsequently, liver samples
was removed and snap frozen in liquid nitrogen.
After sample collection, mice were killed by cervical dislocation.
For collection of primary liver cell samples, another 24micewere in-
fected and six mice each were sacriﬁced on days 21, 32, 42 and 52 post-
infection. In addition, six uninfected mice were used as control samples
and were sacriﬁced on day 0. After in situ digestion with collagenase,
livers were dissected and the mice were killed by cervical dislocation.
2.3. Isolation of mouse hepatocytes, HSCs and hepatic macrophages
The procedure was followed as described previously (He et al.,
2014). The hepatic macrophages were ﬁrst isolated by density-gradient
centrifugation and then puriﬁed using positive selection with magnetic
CD11b antibody beads (MACS, Miltenyi, Auburn, CA). In this study, he-
patic macrophages were deﬁned as CD11b positive cells, and the purity
was determined to be N90% using FACS-Calibur analysis after labelling
puriﬁed cells with anti-CD11b-FITC antibody (Miltenyi) (Fig. S1).
2.4. Liver pathology
Liver specimens were ﬁxed in 5% (v/v) paraformaldehyde, and the
size of hepatic granuloma and the extent of ﬁbrosis were observed by
H&E staining and Masson's trichrome staining of liver sections.2.5. Egg counting
After liver tissue was digested overnight with 4% potassium hydrox-
ide, the total number of schistosome eggs in the liver tissue was count-
ed, and the liver egg burdens were deﬁned as 104 eggs per gram of liver
tissue.
2.6. Cell culture and stimulation
BMDMswere isolated from6 to 8-week-old BABL/cmalemice as de-
scribed (Davis, 2013). Primary cells weremaintained on bacterial grade
plates for 1week in DMEM (Hyclone), supplementedwith 10% fetal bo-
vine serum (Hyclone), 2 mM L-glutamine, 100 units/mL penicillin G,
100 mg/mL streptomycin (Invitrogen) and 5 ng/mL M-CSF (ProSpec).
Adherent cells were then replated on plastic tissue culture plates in
freshmedia and used 24 h after replating. The immortalized rat Kupffer
cell line (purchased from Applied Biological Materials Inc.) was main-
tained in the same media as BMDMs but without M-CSF.
For stimulation, BMDMs or the Kupffer cell line were exposed to re-
combinant IFN-γ, IL-10, IL-4 or IL-13 (ProSpec) after starvation over-
night in 0.5% fetal bovine serum (Hyclone), and harvested at the
appropriate time points.
For transfection, 40 nM miRNA mimics, inhibitors or negative
control (GenePharma, China) was transfected using the Lipofecta-
mine 2000 Transfection Reagent (Life technologies) according to
the manufacturer's instructions.
2.7. RNA extraction and real-time PCR
Total RNAwas extracted using Trizol reagent (Invitrogen) according
to the manufacturer's protocol. Real-time PCR was performed as de-
scribed previously (Schmittgen and Livak, 2008). The expression of
miR-146a, miR-146b, IFN-γ, TNF-α, IL-4, IL-10, IL-13, TGF-β1, iNOS
and Arg-1 was determined using the SYBR Green Master Mix kit
(Takara). GAPDH or U6 snRNAs was used as the internal control for
mRNA or miRNA quantiﬁcation, and the fold change was calculated
using the 2-ΔΔCt method. Supplementary Table S1 shows the primer se-
quences used in this study.
2.8. Western blotting
Cell protein was extracted on ice using RIPA lysis buffer (Beyotime)
in the presence of a freshly added cocktail of protease inhibitors (Ther-
mo), and then quantiﬁed by the BCA method (Pierce). A total of 30 μg
total protein per lane was loaded onto 12% SDS-polyacrylamide gels,
electrophoresed, and then transferred to 0.2-μm nitrocellulose mem-
branes (Pierce) for 1 h at 350 mA using a wet western blotting system.
After blocking with 5% non-fat milk in PBS, themembrane was incubat-
ed with rabbit anti-STAT1 antibody (Epitomics, Cat. 2251–1) or rabbit
anti-phospho-STAT1 (CST, Cat. 7649) overnight at 4 °C. IRDye 800CW
goat anti-rabbit IgG (LI-COR, Cat. 926–32,211) was used as secondary
antibody to display the signal, and rabbit anti-GAPDH (Epitomics, Cat.
2251–1) antibody was used as an internal standard.
2.9. ChIP Assay
ChIP experiments were performed as described elsewhere (Lee et al.,
2006). Sheared chromatin from5×106 BMDMswas immunoprecipitated
overnight at 4 °C using monoclonal rabbit anti-STAT3 (CST, Cat.5397) or
monoclonal rabbit anti-STAT6 (CST, Cat.4904). One percent of the initial
chromatin, not immunoprecipitated, was used as the input. Quantitative
real-time PCR (qPCR)was performed in triplicate by using promoter-spe-
ciﬁc primers (Table S1). Signals from ChIP samples were normalized to
signals fromcorresponding input samples, calculated according to the for-
mula 100 × 2(input Ct − ChIP Ct). Results are expressed in fold-enrichment
relative to control samples.
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LPS levels in serum from portal vein were detected using a
colourmetric assay according to manufacturer's instructions (Chinese
Horseshoe Crab Reagent Manufactory Co., Ltd., China). The minimum
detectable concentration of the kit was 0.01 EU/mL.2.11. Luciferase Reporter Assay
The miR-146b promoter were ampliﬁed from genomic DNA from
BMDMs and cloned in the pGL3-Basic vector (Promega). The structures
of all constructswere conﬁrmed byDNA sequence analysis. For promot-
er luciferase reporter assays, BMDMswere plated at 105 cells per well in
24-well dishes, andwere transiently transfectedwith the indicated con-
structs and pRL-TK-Renilla for 24 h using the Lipofectamine 2000 Trans-
fection Reagent (Life technologies) according to the manufacturer's
instructions, and then the cells were incubated with IL-4, IL-10 or IL-
13. After 12 h, the cells were harvested for the luciferase activity assay.2.12. Statistical analyses
All results are reported as means ± standard deviations. Statistical
evaluation between groups was performed by two-tailed Student's t-
test or one-way ANOVA and is presented in the Figures. P-values
b0.05 were considered statistically signiﬁcant.Fig. 1. Expression ofmiR-146 in liver after S. japonicum infection. (a, b) Change inmiR-146a (a)
samples from uninfectedmice (day 0). (c, d) Hepatocytes, HSCs andmacrophages were isolated
146a or miR-146b in HSCs and macrophages were compared to that in hepatocytes, respect
macrophages after infection. **P b 0.01, ***P b 0.001, compared with samples from uninfected
three independent experiments.3. Results
3.1. Expression of miR-146 in the progression of hepatic schistosomiasis
Liver samples frommice at various time points after S. japonicum in-
fection were collected to analyse liver pathology and miR-146 expres-
sion in the progression of hepatic schistosomiasis. The results of
hematoxylin and eosin (H&E) staining of liver sections revealedmild in-
ﬂammation along with the presence of eggs in the liver tissue starting
from day 32 post-infection. By day 42 post-infection, eggs were
encompassed by a large population of inﬂammatory cells, resulting in
the formation of a mature granuloma with mild extracellular matrix
(ECM) deposition (Fig. S2a). The number of worm pairs in the mesen-
teric veins of mice showed no change during the parasite infection
(Fig. S2b), but the egg burden in liver tissues dramatically increased
after day 32 post-infection (Fig. S2c).
In our previous study, we have shown using miRNA microarrays
that the expression of miR-146 was increased in liver tissues after
S. japonicum infection (He et al., 2015), a similar result was con-
ﬁrmed by RNA-seq method (Cai et al., 2013). To validate these mi-
croarray results, we looked at the expression of miR-146 in liver
tissues by real-time PCR (RT-PCR). As shown in Fig. 1a and b, the ex-
pression levels of both miR-146a and miR-146b in the liver tissues
were signiﬁcantly elevated by day 32 post-infection compared to
that on day 0 (p b 0.001), and peaked at day 42 post-infection follow-
ed by a decrease at day 52. It is well acknowledged that the role of
miRNAs is cell-type speciﬁc, thus we isolated different types ofandmiR-146b (b) levels in liver cells after infection. **P b 0.01, ***P b 0.001, comparedwith
from uninfected (c) and infected (d) livers (day 42 after infection), and the levels of miR-
ively. (e, f, g, h) Change in miR-146a (e), miR-146b (f), iNOS (g) and Arg-1 (h) levels in
mice (day 0). Data are shown as means with SDs. Data in all panels are representative of
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pression. We found that the abundance of miR-146a and miR-146b
in hepatic macrophages was signiﬁcantly higher than that in other
cell types such as hepatocytes and HSCs in the livers of both uninfect-
ed and infected (day 42 post-infection) mice (Fig. 1c and d), suggest-
ing that miR-146 could be involved in the regulation of the function
of hepatic macrophages. It is worthy to point out that the fold change
in hepatic macrophages from uninfected mice was greater than that
from infectedmice. This is because the level ofmiR-146 in uninfected
hepatocytes was much lower than that in the infected hepatocytes
(Fig. S3), while all the fold changes were calculated via comparison
with the levels of uninfected or infected hepatocytes, respectively.
In addition, we analysed the expression of miR-146 in macrophages
during the progression of hepatic schistosomiasis. We found that both
miR-146a and miR-146b were upregulated in macrophages by day 42
post-infection compared to that in uninfected liver. The peaks of miR-
146a and miR-146b expression were similar (Fig. 1e and f).
3.2. miR-146 regulates the differentiation of macrophages in hepatic
schistosomiasis
We analysed the alteration of the immune environment in liver and
the activation status ofmacrophages in the progression of hepatic schis-
tosomiasis. The expression of the Th1 cytokine, such as IFN-γ, was sig-
niﬁcantly increased during the early stage of infection and then
decreased gradually after 32 days post-infection (Fig. S4a and S4b).
However, the expression of the Th2 cytokine was dramatically elevated
at later time points (day 42 and 52 post-infection) (Fig. S4c-4f). Howev-
er, the level of LPS in portal vein serum did not change during the ob-
served time period (Fig. S5).
Inducible nitric oxide synthase (iNOS) is a marker of M1 macro-
phages while arginase 1 (Arg-1) is an M2 marker. As shown in Fig. 1g
and h, iNOS expression increased by day 32 and peaked at day 42,
followed by a decrease at day 52. Contrarily, Arg-1 expression wasFig. 2.miR-146 blocked the differentiation of macrophages to M1 cells. A Kupffer cell line was
transfection reagent only (mock) for 24 h, then stimulated with IFN-γ for 24 h. Total RNA wa
by qPCR. Data are shown as means with SDs. Data in all panels are representative of four indepsigniﬁcantly upregulated by day 42 and the highest expression level
was observed on day 52. The concomitant alteration in the expression
of both iNOS and miR-146 in macrophages led us to the question
whether miR-146 could inhibit the differentiation of macrophages
into M1 cells. In order to test this, a Kupffer cell line was transfected
with miR-146a and miR-146b, respectively, and then stimulated with
IFN-γ. Our data showed a signiﬁcant decrease in the expression of
iNOS and TNF-α in Kupffer cells transfected with miR-146a and miR-
146b and stimulated by IFN-γ (Fig. 2a and b). The expression of M2
markers, Arg-1 and TGF-β1 remained unchanged (Fig. 2c and d). This
suggests that both miR-146a and miR-146b affect the differentiation
of macrophages into M1 cells. Further, we veriﬁed this phenomenon
by using bone marrow derived macrophages (BMDMs), where both
miR-146a and miR-146b inhibited the IFN-γ-induced differentiation
into M1 cells with a signiﬁcant reduction in the expression levels of
M1 markers (Fig. S6).
3.3. STAT1 is a target of miR-146 in macrophages
STAT1 is a pivotal molecule in IFN-γ signal transduction, thus this
molecule could play an important role in M1 activation. It is intriguing
that STAT1 is a predicted target of miR-146 in the TargetScan database,
whichwas validated in regulatory T cells (Lu et al., 2010) and also in pe-
ripheral blood mononuclear cells (Tang et al., 2009). To analyse the re-
lationship between miR-146 and STAT1 in macrophages, we detected
the expression pattern of STAT1 in hepatic macrophages with the pro-
gression of hepatic schistosomiasis. We found that STAT1 expression
in hepatic macrophages was elevated at day 21 and 32, followed by a
dramatic decrease at day 42 and 52 (Fig. 3a), which contrasts with the
expression pattern of miR-146 in macrophages (Fig. 1e and f), implying
that miR-146 could regulate STAT1 expression. Further, we transfected
miR-146a/b into the Kupffer cell line and detected the expression of
STAT1 by RT-PCR. As shown in Fig. 3b, miR-146 signiﬁcantly inhibited
the expression of STAT1 in Kupffer cell. This result was also validatedtransfected with 40 nMmiR-146a, miR-146b mimics, a negative control miRNA (NC), or
s collected and analysed for expression of iNOS (a), TNF-α (b), Arg-1 (c), or TGF-β1 (d)
endent experiments.
Fig. 3. Target validation of miR-146. (a) STAT1 expression in hepatic macrophages after S. japonicum infection. *P b 0.05, **P b 0.01, ***P b 0.001, compared with samples from uninfected
mice (day 0). (b, c, d) A Kupffer cell linewas transfectedwith 40 nMmiR-146a, miR-146bmimics, a negative control miRNA (NC), or transfection reagent only (mock) for 48 h, then total
RNAand proteinwere collected and analysed for expression of STAT1 by qPCR (b) andwestern blot (c, d), respectively. (e, f) A Kupffer cell linewas transfectedwith 40 nMmiR-146a,miR-
146bmimics, a negative control miRNA (NC), or transfection reagent only (mock) for 42 h, then stimulatedwith IFN-γ for 6 h, and total proteinwas collected and analysed for expression
of phospho-STAT1 by western blot. Data are shown as means with SDs. Data in all panels are representative of three independent experiments.
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using BMDMs of mice and found that miR-146a/b transfection signiﬁ-
cantly inhibited STAT1 expression in BMDMs (Fig. S7). These data dem-
onstrated that STAT1 is a target of miR-146 inmacrophages. In addition,
STAT1 phosphorylation is responsible for the deﬁnitive function of
STAT1, thus, we analysed the effect of miR-146a/b on STAT1 phosphor-
ylation, and we found, as expected, when the Kupffer cells were
transfected with miR-146a or b in advance, the phosphorylated STAT1
in Kupffer cells after IFN-γ stimulation was obviously decreased (Fig.
3e and f).
3.4. Th2 cytokines induced the expression of miR-146b in BMDMs
The interplay of various cytokines, including both Th1 and Th2 cyto-
kines, has a crucial role in the pathology andprogression of hepatic schis-
tosomiasis. Thus, we speculated whether the expression of miR-146 in
hepatic macrophages is modulated by the cytokines. We noticed that
the expression of all the Th2 cytokines (IL-4, IL-10, IL-13 and TGF-β1)in the livers were upregulated post-infection (Fig. S4c-4f), andwere cor-
related with the expression pattern of miR-146 in the livers (Fig. 1a and
b). To determine whether these cytokines regulated the expression of
miR-146, we stimulated BMDMs with recombinant cytokines in vitro.
As shown in Fig. 4a and b, IL-4, IL-10, and IL-13 signiﬁcantly induced
the expression of miR-146b, but not miR-146a. Next, we investigate
the molecular pathway leading to the induction of miR-146b expression
by the cytokines. Themouse pre-miR-146b gene resides in the ﬁrst intron
of an annotated gene named tmem180 (Fig. 5a). However, the cytokines,
including IL-4, IL-10, or IL-13 had no effect on the expression of tmem180
gene (Fig. 4c), implying thatmiR-146b could be transcribed independent
of tmem180 transcript in macrophages. Then, we looked at the putative
promoter regions covering 2000 bp upstream of the coding region of
pre-miR-146b, and identiﬁed one conserved putative binding site for
STAT3, one site for STAT6, and one site for both STAT3 and STAT6 (Fig.
5a). The STAT3 and STAT6 are the main transcription factors mediating
IL-10 and IL-4/13 signalling, respectively, and it has been shown that
miR-146b is a direct target gene of STAT3 (Curtale et al., 2013; Xiang et
Fig. 4. IL-4/10/13 inducedmiR-146 expression in BMDMs. Expression levels ofmiR-146a (a),miR-146b (b) and Tmem180 (c) in BMDMs after stimulationwith TGF-β1, IL-4, IL-10, or IL-13
for 12 h. *P b 0.05, **P b 0.01, ***P b 0.001, comparedwith blank control samples. Data are shown asmeanswith SDs. Data in all panels are representative of four independent experiments.
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lating the Th2 cytokine-dependent transcription, we generated a con-
struct expressing luciferase under the control of the putative promoter
(Fig. 5a). We showed that all the Th2 cytokines including IL-4, IL-10,
and IL-13 signiﬁcantly upregulated the expression of the luciferase re-
porter gene in BMDMs (Fig. 5b), which indicated that the STAT3- and
STAT6- binding sites in the promoter mediate the cytokine-dependent
transcription. In addition, we used ChIP analysis to further validate the
activity of these putative binding sites. In the ChIP analysis, we designed
two pairs of primers to detect the binding of STAT3/6 to these putative
sites, one of which (primer 1) covered the STAT6 site, and the other
(primer 2) covered the STAT3 site and common site for STAT3/6
(Fig. 5a). Our results showed that, in IL-10 stimulated macrophages,
STAT3 was recruited to the pre-miR-146b promotor, as the enrichment
of putative STAT3 site detected by primer 2 was signiﬁcantly elevated
after stimulation. STAT6-dependant recruitment to the pre-miR-146b
promotor was also observed in the IL-4/13 stimulated macrophages,
but STAT6 seemed to bind to different regions in different situations. In
IL-4 stimulated macrophages, STAT6 was recruited to the regionFig. 5. IL-4/10/13 induced miR-146 expression in BMDMs by activating the promoter of th
chromosome 19. Predicted binding sites of STAT3 (black) and STAT6 (white) transcription f
146b locus was analysed in a promoter luciferase reporter assay. *P b 0.05, **P b 0.01, ***P b 0
10 or IL-13, or not stimulated (control), and ChIP assays were carried out by using anti-STAT3
146b promoter. Data are shown as means with SDs. Data in all panels are representative of thrdetected by primer 2, while in IL-13 stimulated macrophages, STAT6
was recruited to the region detected by primer 1 (Fig. 5c).3.5. Th2 cytokines inhibit the differentiation of macrophages to M1 cells by
induction of miR-146b
Th2 cytokines can block IFN-γ-induced activation of macrophages,
but the mechanism is not yet clear (Sica and Mantovani, 2012). As
shown in Fig. 6a, all the Th2 cytokines including IL-4, IL-10 and IL-13 po-
tently inhibited IFN-γ-induced iNOS production in the Kupffer cell line.
We postulated that these cytokines induced the elevation of miR-146b,
which in turn blocked the activation of themacrophages. To test this,we
ﬁrst transfected Kupffer cells with either transfection reagent (mock
group) or negative control inhibitors (NC group) ormiR-146b inhibitors
(anti-miR-146b group), and then stimulated them with IL-4 or IL-10 or
IL-13, followed by IFN-γ stimulation. Our data showed that compared
with mock and NC group, the expression of iNOS in the anti-miR-146b
group was signiﬁcantly elevated, indicating that downregulation ofe pre-miR-146 gene. (a) Schematic diagram of the miR-146b genomic locus on murine
actors are shown as boxes. (b) The genomic region indicated by the bar above the miR-
.001, compared with control samples. (c) BMDMs were stimulated for 12 h with IL-4, IL-
or anti-STAT6 antibody and analysed by qPCR with speciﬁc primers binding to themiR-
ee independent experiments.
Fig. 6. Inhibition ofmiR-146b blocked the effect of IL-4/10/13 on the IFN-γ-induced activation ofmacrophages. (a) iNOSproduction in a Kupffer cell line pretreatedwith IL-4, IL-10 or IL-13
for 12 h, followed by the addition of IFN-γ. (b) A Kupffer cell linewas transfected with 40 nMmiR-146b inhibitor, negative control inhibitor (NC), or transfection reagent only (mock) for
12 h, then pretreated with IL-4 or IL-10 or IL-13 for 12 h, followed by the addition of IFN-γ. Total RNA was extracted and analysed for iNOS expression by qPCR. Data are shown as means
with SDs. Data in all panels are representative of four independent experiments.
345X. He et al. / EBioMedicine 13 (2016) 339–347miR-146b expression relieved the inhibitory effect of the Th2 cytokines
on the IFN-γ-induced activation of M1 macrophages (Fig. 6b).
4. Discussion
Macrophages have been reported tomodulate the initiation,mainte-
nance, and resolution of schistosomiasis through differentiating to var-
ious activation states, and therefore, a therapy designed to manipulate
macrophage activation could be a relevant approach to treat this chron-
ic disease. However, to date, nowell-validated targets have been identi-
ﬁed inmacrophages in order to treat this disease. In this study,we found
that miR-146a/b were primarily expressed in the hepatic macrophages,
and thatmiR-146a/b inhibited the differentiation ofmacrophages toM1
cells by targeting STAT1. Importantly, we found that various Th2 cyto-
kines, including IL-4, IL-10, and IL-13, could induce macrophages to ex-
press miR-146b, but not miR-146a, by activating the promoter of pre-
miR-146b gene. Further, these cytokines could potently block the differ-
entiation of macrophages to M1 macrophages, partly by induction of
miR-146b. Thus, our data indicated that miR-146 played an important
role in the regulation of macrophage activation during hepatic
schistosomiasis.
Schistosomes are a prime example of a complex multicellular path-
ogen that survives in the host despite the development of a signiﬁcant
immune response, and understanding how the immune system acts
against this parasite is still a daunting challenge. It is well documented
that macrophages, key cells of the immune system, play a central role
in the immunopathology induced by schistosome eggs by differentiat-
ing into various phenotypes. Several studies have highlighted that
prompt transition of macrophages from M1 cells to M2 cells is critical
for the host to survive in cases of acute schistosomiasis (Herbert et al.,
2004), however, little is known about the mechanisms that regulate
the transition between macrophage phenotypes. Here, our study im-
plies that miR-146 might be an important mediator in this process,
and our data suggest that at the early stage of infection including themi-
gration of the schistosomula and adult worms, the dominant immune
response is Th1 type and elevated IFN-γ levels stimulate macrophages
to differentiate to M1 cells through activation of STAT1. When the par-
asites begin to produce eggs, the host immunity switches to a Th2 re-
sponse and upregulated Th2 cytokines begin to induce the
macrophages to differentiate to M2 cells, and meanwhile, these
cytokines such as IL-10 and IL-4/13 also induce the expression of miR-
146b by activating STAT3/6, which bind to the promoter of the pre-
miR-146b gene and initiate transcription. The resulting miR-146b
further inhibits the differentiation of M1 macrophages by targeting
STAT1 (Fig. 7). Considering the fact that prompt transition of macro-
phages from M1 cells to M2 cells is critical for host to survive in theacute schistosomiasis, we speculated that miR-146 could be a crucial
protective factor for host in the acute stage of infection, and played an
important role in the transition from acute to chronic infection. It is
worthy to point out that, though we did not explore it in this study,
miR-146 might also be involved in the regulation of other immune
cells, such as B cells and T cells, which are essential for the development
of hepatic schistosomiasis (Pearce and MacDonald, 2002).
Schistosomiasis is a debilitating and chronic disease associated with
egg-induced inﬂammation, tissue damage, and subsequent ﬁbrosis. The
highly desirable outcome in the treatment of schistosomiasis is to re-
solve inﬂammation, reverse ﬁbrosis, and restore normal tissue architec-
ture and function (Barron and Wynn, 2011). Numerous studies have
established that M1 macrophages are related to inﬂammation and tis-
sue damage, but are capable of remodelling the ECMs, while M2macro-
phages are essential for hosts to survive the acute phase of infection, but
are involved in ﬁbrosis (Barron and Wynn, 2011). Thus, therapies de-
signed to manipulate macrophage activation appear suitable for
treating this chronic disease. It is reasonable that development of slight-
ly more M1 than M2 macrophages will be beneﬁcial to provide the
greatest degree of protection during infection by minimizing ﬁbrosis,
while simultaneously protecting the host from tissue damage. In this
study, we have investigatedwhethermiR-146 couldmanipulatemacro-
phage activation and have a potential for treating schistosomiasis
through regulating differentiation of macrophages. S. japonicum infec-
tion can elevate the expression of miR-146 that could block differentia-
tion of hepatic macrophages into M1 cells by targeting STAT1. Thus,
manipulation of the expression of miR-146 could result in more macro-
phages differentiating into M1-type, leading to elevated iNOS expres-
sion that might attenuate the formation of egg granuloma and ﬁbrosis
(Wynn et al., 1995). In addition, the degree of target inhibition imposed
by miRNAs always tends to be modest (Ebert and Sharp, 2012), thus,
through intervening miRNA expression, the pathway regulated by
miRNA in macrophages seemed not to be totally blocked or activated,
which is essential for hosts to survive in the course of infection. There-
fore, miR-146 appears to be an ideal target tomanipulatingmacrophage
activation. However, we have to admit that the hepatic macrophages,
deﬁned as CD11b positive cells in this study, might be a mixed popula-
tion (a proliferating residentmacrophages andmonocyte-derivedmac-
rophages), especially at latter infection time, as a recent study has
shown thatmacrophages in the hepatic granulomaswere predominant-
ly derived from monocytes during S. mansoni infection (Nascimento et
al., 2014).
miR-146a and miR-146b are two miRNAs of the same family that
share the same seed sequence and only differ by two nucleotides at
the 3′ end in theirmature sequences. However, they are encoded by dis-
tinct genes located on separate chromosomes, which implies that they
Fig. 7. Schematic diagram of the role of miR-146b in the regulation of activation ofmacrophages during hepatic schistosomiasis. At the early stage of infection, the schistosomula and adult
worms induced Th1 immune response and elevated IFN-γ level that stimulates the differentiation of macrophages to M1 cells through activation of STAT1. When the parasites begin to
produce eggs, the host immune response switches from a Th1 to a Th2 type and upregulated Th2 cytokines such as IL-4/13 that stimulate differentiation of macrophages to M2 cells
through activation of STAT6. Meanwhile, the Th2 cytokines of IL-10 and IL-4/13 induce the expression of miR-146b by activating STAT3 and STAT6, respectively, which bind to the
promoter of the pre-miR-146b gene and initiate transcription. The resulting miR-146b inhibits the differentiation of M1 macrophages by targeting STAT1.
346 X. He et al. / EBioMedicine 13 (2016) 339–347may fulﬁl distinct functions. Indeed, experimental evidences have dem-
onstrated that bothmiR-146a andmiR-146b are involved in the regula-
tion ofmacrophage activation, but their target genes andbiological roles
are different (Nahid et al., 2011; Saba et al., 2014). The gene encoding
miR-146a in macrophages was rapidly induced by pro-inﬂammatory
factors, such as LPS and IL-1β, which activate the nuclear factor kappa
B (NF-κB) pathway, but the elevatedmiR-146a blocks further activation
of NF-κB signaling, forming a negative feedback loop (Perry et al., 2008;
Taganov et al., 2006).WhilemiR-146b expression is also enforced in the
macrophages by LPS stimulation with delayed kinetics with respect to
miR-146a and via an IL-10-mediated STAT3-dependent transcription,
indicating that miR-146b is involved in the IL-10-dependent resolution
phase of inﬂammation (Curtale et al., 2013). In addition, several studies
have revealed that miR-146a directly inhibits the activation of M1
macrophage and plays an important role in the pathogenesis of human
diseases, such as Brugia malayi infection (Rückerl et al., 2012), mycobac-
terial exposure (Li et al., 2016), and nephropathy (Bhatt et al., 2016). By
contrast, miR-146b has not been reported to have such a function. In this
study, we found that, although both miR-146a and miR-146b were up-
regulated in the process of schistosome infection, only miR-146b could
be induced by a series of Th2 cytokines involved in the chronic stage of
infection, by activating STAT3/6, and the Th2 cytokines, at least partly,
inhibited the differentiation of macrophages to M1 cells by induction of
miR-146b through targeting STAT1. Thus, our study further demonstrat-
ed the distinct regulations and biological roles of miR-146a and miR-
146b in macrophages. Importantly, data from this study reveal an inhib-
itory effect of Th2 cytokines such as IL-10 and IL-4/13 on the activation of
M1 macrophages through induction of miR-146b.
In summary, considering the role of macrophages in the hepatic im-
munopathology induced by schistosome eggs, there is a need to explore
therapeutic strategies designed tomanipulatemacrophage activation to
treat this chronic disease. Our data indicate the protective roles of miR-
146a/b in hepatic schistosomiasis through regulating differentiation of
macrophages into M2 cells.
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